Search tool

Displaying 1 - 10 of 206

Document library

Continuity and change: high-risk drug use and drug treatment in Europe 2014

Meeting proceedings include the programme, summaries of all sessions and abstracts of presentations presented during the EMCDDA event incorporating the Treatment Demand and High-Risk Drug Use/Problem Drug Use key epidemiological indicators expert...

Document library

Serbia National Strategy for the Prevention of Drug Abuse 2014-2021

The Strategy for the Prevention of Drug Abuse for the period 2014–2021 is the key document for solving the issues of drug abuse. It is harmonised with the national state of play...

Video thumbnail: naloxone

Video: Take-home naloxone programmes in Europe — overdose prevention

Drug overdose continues to be the main cause of death among problem drug users and heroin or its metabolites are present in the majority of reported fatal overdoses. Naloxone is a lifesaving...

Document library

Data protection record on EMCDDA wardens (DPO-038)

All EU institutions have the legal obligation to keep a central register of records of activities processing personal data (Article 31 of Regulation 2018/1725). For more information or to see more EMCDDA...

Document library

Agenda and minutes of the 50th EMCDDA Management Board meeting (4-5 December 2014)

Agenda and minutes of the 50th EMCDDA Management Board meeting, 4-5 December 2014.

Document library

EMCDDA policy for the prevention and management of conflicts of interest

The Common Approach endorsed by the European Parliament, the Council and the Commission in July 2012 (as attached to the Joint Statement on EU decentralised agencies signed by these three institutions, see...

50th meeting of EMCDDA Management Board

04.12.2014 to 05.12.2014

The Management Board is the main decision-making body of the EMCDDA. It meets at least once a year and consists of one representative from each Member State of the European Union, two...

Lisbon, Portugal

EMCDDA statutory body meeting

Document library

Current European data collection on emergency department presentations with acute recreational drug toxicity: Gaps and national variations

The systematic collection of data on ED presentation of toxicity related to NPS and classical drugs in Europe is scarce and the collection of data is highly variable between different countries. Euro-DEN...

Financing drug policy in Europe in the wake of the economic recession

The economic crisis that Europe experienced in 2008 and later presented a grave challenge to public finances. Countries responded to this by undertaking fiscal consolidation. By examining public expenditure in the areas...

Gaps in HIV prevention expose Europe to risk of outbreaks

In Europe, decades of investment in effective HIV prevention measures targeting people who inject drugs continue to bear fruit as demonstrated by the long-term decline in HIV diagnoses related to drug injecting...